A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
BG9928 in Subjects With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS
- Status
- COMPLETED
- Phase
- PHASE1
BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects
- Status
- COMPLETED
- Phase
- PHASE3
A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function
- Status
- COMPLETED
- Phase
- N/A
Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy
- Status
- WITHDRAWN
- Phase
- PHASE4
Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability of Repeat Courses of IM Alefacept
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients
- Status
- TERMINATED
- Phase
- PHASE3
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a
- Status
- WITHDRAWN
- Phase
- PHASE4
Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri
- Status
- TERMINATED
- Phase
- PHASE4
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
- Status
- TERMINATED
- Phase
- PHASE2